La Sala L, Pontiroli AE. Prevention of diabetes and cardiovascular disease in obesity. Int J Mol Sci. 2020;21:8178.
Article PubMed PubMed Central Google Scholar
Mukorako P, Lemoine N, Biertho L, Lebel S, Roy MC, Plamondon J, et al. Consistent gut bacterial and short-chain fatty acid signatures in hypoabsorptive bariatric surgeries correlate with metabolic benefits in rats. Int J Obes. 2022;46:297–306.
Li JV, Ashrafian H, Sarafian M, Homola D, Rushton L, Barker G, et al. Roux-en-Y gastric bypass-induced bacterial perturbation contributes to altered host-bacterial co-metabolic phenotype. Microbiome. 2021;9:139.
Article CAS PubMed PubMed Central Google Scholar
West KA, Kanu C, Maric T, McDonald JAK, Nicholson JK, Li JV, et al. Longitudinal metabolic and gut bacterial profiling of pregnant women with previous bariatric surgery. Gut. 2020;69:1452–9.
Paganelli FL, Luyer M, Hazelbag CM, Uh HW, Rogers MRC, Adriaans D, et al. Roux-Y Gastric Bypass and Sleeve Gastrectomy directly change gut microbiota composition independent of surgery type. Sci Rep. 2019;9:10979.
Article PubMed PubMed Central Google Scholar
Steinert RE, Rehman A, Souto Lima EJ, Agamennone V, Schuren FHJ, Gero D, et al. Roux-en-Y gastric bypass surgery changes fungal and bacterial microbiota in morbidly obese patients-A pilot study. PloS One. 2020;15:e0236936.
Article CAS PubMed PubMed Central Google Scholar
Huh YJ, Seo JY, Nam J, Yang J, McDowell A, Kim YK, et al. Bariatric/metabolic surgery induces noticeable changes of microbiota and their secreting extracellular vesicle composition in the gut. Obes Surg. 2019;29:2470–84.
Lu C, Li Y, Li L, Kong Y, Shi T, Xiao H, et al. Alterations of serum uric acid level and gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in a hyperuricemic rat model. Obes Surg. 2020;30:1799–807.
Article PubMed PubMed Central Google Scholar
Dao MC, Belda E, Prifti E, Everard A, Kayser BD, Bouillot JL, et al. Akkermansia muciniphila abundance is lower in severe obesity, but its increased level after bariatric surgery is not associated with metabolic health improvement. Am J Physiol Endocrinol Metab. 2019;317:E446–e59.
Article CAS PubMed Google Scholar
Ye Y, Abu El Haija M, Morgan DA, Guo D, Song Y, Frank A, et al. Endocannabinoid Receptor-1 and sympathetic nervous system mediate the beneficial metabolic effects of gastric bypass. Cell Rep. 2020;33:108270.
Article CAS PubMed PubMed Central Google Scholar
Azar S, Sherf-Dagan S, Nemirovski A, Webb M, Raziel A, Keidar A, et al. Circulating endocannabinoids are reduced following bariatric surgery and associated with improved metabolic homeostasis in humans. Obes Surg. 2019;29:268–76.
Guijarro A, Osei-Hyiaman D, Harvey-White J, Kunos G, Suzuki S, Nadtochiy S, et al. Sustained weight loss after Roux-en-Y gastric bypass is characterized by down regulation of endocannabinoids and mitochondrial function. Ann Surg. 2008;247:779–90.
Lacroix S, Pechereau F, Leblanc N, Boubertakh B, Houde A, Martin C, et al. Rapid and concomitant gut microbiota and endocannabinoidome response to diet-induced obesity in mice. mSystems. 2019;4:407–19.
Manca C, Boubertakh B, Leblanc N, Deschênes T, Lacroix S, Martin C, et al. Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling. J Lipid Res. 2020;61:70–85.
Article CAS PubMed Google Scholar
Hankir MK, Seyfried F, Hintschich CA, Diep TA, Kleberg K, Kranz M, et al. Gastric bypass surgery recruits a gut PPAR-α-Striatal D1R pathway to reduce fat appetite in obese rats. Cell Metab. 2017;25:335–44.
Article CAS PubMed Google Scholar
Hutch CR, Trakimas DR, Roelofs K, Pressler J, Sorrell J, Cota D, et al. Oea signaling pathways and the metabolic benefits of vertical sleeve gastrectomy. Ann Surg. 2020;271:509–18.
Baraboi ED, Li W, Labbé SM, Roy MC, Samson P, Hould FS, et al. Metabolic changes induced by the biliopancreatic diversion in diet-induced obesity in male rats: the contributions of sleeve gastrectomy and duodenal switch. Endocrinology. 2015;156:1316–29.
Article CAS PubMed Google Scholar
Mukorako P, Lopez C, Baraboi ED, Roy MC, Plamondon J, Lemoine N, et al. Alterations of gut microbiota after biliopancreatic diversion with duodenal switch in wistar rats. Obes Surg. 2019;29:2831–42.
Turcotte C, Dumais É, Archambault AS, Martin C, Blanchet MR, Bissonnette É, et al. Human leukocytes differentially express endocannabinoid-glycerol lipases and hydrolyze 2-arachidonoyl-glycerol and its metabolites from the 15-lipoxygenase and cyclooxygenase pathways. J Leukoc Biol. 2019;106:1337–47.
Article CAS PubMed Google Scholar
Parks DH, Tyson GW, Hugenholtz P, Beiko RG. STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics. 2014;30:3123–4.
Article CAS PubMed PubMed Central Google Scholar
Depommier C, Vitale RM, Iannotti FA, Silvestri C, Flamand N, Druart C, et al. Beneficial effects of Akkermansia muciniphila are not associated with major changes in the circulating Endocannabinoidome but linked to higher Mono-Palmitoyl-Glycerol levels as new PPARα agonists. Cells. 2021;10:185.
Article CAS PubMed PubMed Central Google Scholar
Borrelli F, Izzo AA. Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance. Best Pract Res Clin Endocrinol Metab. 2009;23:33–49.
Article CAS PubMed Google Scholar
Gagner M. Hypoabsorption not malabsorption, hypoabsorptive surgery and not malabsorptive surgery. Obes Surg. 2016;26:2783–4.
Kapeluto JE, Tchernof A, Masckauchan D, Biron S, Marceau S, Hould FS, et al. Ten-year remission rates in insulin-treated type 2 diabetes after biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis. 2020;16:1701–12.
Harris LA, Kayser BD, Cefalo C, Marini L, Watrous JD, Ding J, et al. Biliopancreatic diversion induces greater metabolic improvement than Roux-en-Y gastric bypass. Cell Metab. 2019;30:855–64.e3.
Article CAS PubMed PubMed Central Google Scholar
Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577–85.
Article CAS PubMed Google Scholar
Chambers AP, Jessen L, Ryan KK, Sisley S, Wilson-Pérez HE, Stefater MA, et al. Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology. 2011;141:950–8.
Article CAS PubMed Google Scholar
Miras AD, le Roux CW. Mechanisms underlying weight loss after bariatric surgery. Nat Rev Gastroenterol Hepatol. 2013;10:575–84.
Sinclair P, Brennan DJ, le Roux CW. Gut adaptation after metabolic surgery and its influences on the brain, liver and cancer. Nat Rev Gastroenterol Hepatol. 2018;15:606–24.
Article CAS PubMed Google Scholar
Di Marzo V, Silvestri C. Lifestyle and metabolic syndrome: contribution of the endocannabinoidome. Nutrients. 2019;11:1956.
Article PubMed PubMed Central Google Scholar
van de Wouw M, Schellekens H, Dinan TG, Cryan JF. Microbiota-Gut-Brain axis: modulator of host metabolism and appetite. J Nutr. 2017;147:727–45.
Fujimori K. Prostaglandins as PPARγ modulators in adipogenesis. PPAR Res. 2012;2012:527607.
Article PubMed PubMed Central Google Scholar
Donvito G, Piscitelli F, Muldoon P, Jackson A, Vitale RM, D’Aniello E, et al. N-Oleoyl-glycine reduces nicotine reward and withdrawal in mice. Neuropharmacology. 2019;148:320–31.
Article CAS PubMed Google Scholar
Takenouchi R, Inoue K, Kambe Y, Miyata A. N-arachidonoyl glycine induces macrophage apoptosis via GPR18. Biochem Biophys Res Commun. 2012;418:366–71.
Article CAS PubMed Google Scholar
Kohno M, Hasegawa H, Inoue A, Muraoka M, Miyazaki T, Oka K, et al. Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18. Biochem Biophys Res Commun. 2006;347:827–32.
Article CAS PubMed Google Scholar
McHugh D, Hu SS, Rimmerman N, Juknat A, Vogel Z, Walker JM, et al. N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor. BMC Neurosci. 2010;11:44.
留言 (0)